ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1221

The Effects Of Hyperthyroidism On Bone Mineral Density At Different Sites- An Observational Case-Control Study

Christopher Varley1, Alexander Oldroyd1 and Marwan Bukhari2, 1Lancaster Medical School, Lancaster University, Lancaster, United Kingdom, 2Department of Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Bone density, Dual energy x-ray absorptiometry (DEXA), spine involvement and thyroid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease: Clinical Aspects and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Hyperthyroidism has been described as a risk factor for poor bone health.1, 2 The FRAXTM tool has been used to identify the ten year risk of fracture by utilising hip bone mineral density (BMD) only. If hyperthyroidism is predominantly associated with bone loss in the lumbar spine, the fracture risk in these patients may have been underestimated. No previous study has examined the differential amount of bone loss in hyperthyroidism. This study will determine the extent and site of bone loss in patients with primary hyperthyroidism compared to controls, looking at lumbar spine and femoral neck BMD.

Methods:

Using a nested case-control approach, a cohort of patients referred between 2004 and 2011 for a dual-energy x-ray absorptiometry scan with hyperthyroidism as their main risk factor was identified. These were then age and gender matched with controls referred in the same time period with no indication for scanning. Sites of bone loss were ascertained by comparing the BMD in two areas (L1-L4 vertebrae and the left femoral neck) between cases and controls, using students T-test. A logistic model was then fitted to determine the odds of having a significantly reduced BMD with a diagnosis of hyperthyroidism. The fit of the model was tested using receiver operating characteristic (ROC) curves.

Results:

232 patients with current hyperthyroidism were identified, comprising 184 females (79.7%), with a mean age of 62 (SD 10.7). 232 controls were age and sex matched. Simple comparisons between cases and controls were identified using the students t-test; mean difference between L1-L4 BMD was 0.085 g/cm2 (95% CI 0.051- 0.119) and femoral neck BMD difference was 0.057 g/cm2(95% CI 0.031- 0.083); both had a p-value ≤0.001. The odds of having a significantly reduced BMD was found to be greater in the femoral neck, with an odds ratio of  19.4 for femoral neck BMD (95% CI 4.8-79.0)  compared with 12.2 for L1-L4 BMD (95% CI 4.3-34.8). When the area under the ROC curve was calculated for both L1-L4 and femoral neck BMD, the result was a similar sensitivity and specificity, with an area under the ROC curve of 0.63 for L1-L4 BMD, and an area of 0.62 for the femoral neck.

Conclusion:

Both hip BMD and lumbar spine BMD are significantly reduced in thyrotoxic patients- while BMD loss was found to be greater in the femoral neck than in the lumbar spine, this was only marginally more. Further analysis looking at whether this risk factor has more implications on fracture risk than those used in the FRAXTM tool is needed.

References:

1.            Gogakos AI, Duncan Bassett JH, Williams GR. Thyroid and bone. Archives of Biochemistry and Biophysics. 2010;503(1):129-36.

2.            Nicholls JJ, Brassill MJ, Williams GR, Bassett JHD. The skeletal consequences of thyrotoxicosis. Journal of Endocrinology. 2012;213(3):209-21.


Disclosure:

C. Varley,
None;

A. Oldroyd,
None;

M. Bukhari,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effects-of-hyperthyroidism-on-bone-mineral-density-at-different-sites-an-observational-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology